Wird geladen...
The development of immunoconjugates for targeted cancer therapy
Immunoconjugates are specific, highly effective, minimally toxic anticancer therapies that are beginning to show promise in the clinic. Immunoconjugates consist of three separate components: an antibody that binds to a cancer cell antigen with high specificity, an effector molecule that has a high c...
Gespeichert in:
| Veröffentlicht in: | Nat Rev Clin Oncol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4700536/ https://ncbi.nlm.nih.gov/pubmed/25265912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2014.159 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|